(Nasdaq: MIRM), a leading rare disease company, today announced completion of enrollment in the Phase 3 AZURE-1 study and completion of screening in the Phase 3 AZURE-4 study, both evaluating ...

The actor Chadwick Boseman was a playwright, too. At Shakespeare’s Globe in London, his “Deep Azure” is drawing attention to ...

Conference call to provide business updates today, February 25 at 1:30 p.m. PT/4:30 p.m. ET. FOSTER CITY, Calif., February 25 ...

Peetz announced 2026 net product sales guidance of $630 million to $650 million. He emphasized pipeline progress, noting the approval of CTEXLI for CTX, a tablet formulation of LIVMARLI, and ...

The late actor’s writing was overshadowed by roles in blockbusters. Now, Tristan Fynn-Aiduenu is giving his play about grief the audience it deserves ...

Newsweek compares and contrasts AWS' and Salesforce's new AI agent suites after exclusive interviews with top execs.

Certify360.ai exam preparation Now Offers Exam Prep for 100 Professional Certifications from AWS, Microsoft, Google, ...

Mirum Pharmaceuticals reported strong FY 2025 revenues, capping an exceptional year of growth and pipeline expansion. Learn more about MIRM stock here.

Mirum Pharmaceuticals MIRM reported a loss of 11 cents per share in fourth-quarter 2025, against the Zacks Consensus Estimate ...

Upwind, a leading cloud security provider, enhances its presence in India to meet rising demand for cloud risk management as AI adoption accelerates. Discover their strategic initiatives, local ...

Despite drastic price increases, few companies have completely abandoned VMware. A study shows: 86 percent are actively ...

New support for Cloudflare, Akamai, Fastly, and F5 targets ransomware and misconfiguration recovery for network control plane ...